Myocardial Infarction
📧 Sign up to get email alerts when something new happens for Myocardial Infarction.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2021-02-16Clinical Trial Update: COOL AMI EU Pivotal Trial to Assess Cooling as an Adjunctive Therapy to PCI In Patients With Acute MI (Phase A) [NA]
A Phase A trial update studying hypothermia as an adjunct to PCI in acute myocardial infarction has completed and posted results.
-
CLINICAL_TRIALS trial_result · 2021-02-12Clinical Trial Update: Beta-cell Function in Glucose Abnormalities and Acute Myocardial Infarction [Phase 4]
Phase 4 trial update investigating beta-cell function in glucose abnormalities related to myocardial infarction and unstable angina. Complet…
-
CLINICAL_TRIALS trial_result · 2021-02-04Clinical Trial Update: Myocardial Infarction, COmbined-device, Recovery Enhancement Study [NA]
Clinical trial update for a combined-device recovery enhancement study in acute myocardial infarction with completed status and results post…
-
CLINICAL_TRIALS trial_result · 2021-02-03Clinical Trial Update: STem cElls Mobilization in Acute Myocardial Infarction Outcome Trial [Phase 3]
Phase 3 trial investigating stem cell mobilization in acute myocardial infarction was terminated.
-
CLINICAL_TRIALS trial_result · 2021-02-03Clinical Trial Update: A Phase 2 Open Label Study to Assess the PK/PD Properties of RUC-4 in Patients With a ST-elevation Myocardial Infarction [Phase 2]
Phase 2 open-label study reporting PK/PD properties of RUC-4 in patients with ST-elevation myocardial infarction (STEMI).
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
EMA withdrawal · 2021-01-25EMA Withdrawn: Clopidogrel ratiopharm GmbH (clopidogrel) — Archie Samiel s.r.o.
EMA withdrew clopidogrel from Archie Samiel s.r.o.'s product line, with therapeutic areas including peripheral vascular diseases, acute coro…
-
CLINICAL_TRIALS trial_result · 2021-01-20Clinical Trial Update: Vest Prevention of Early Sudden Death Trial and VEST Registry [NA]
Clinical trial update for the Vest Prevention of Early Sudden Death Trial and VEST Registry, completed with results posted in 2021.
-
CLINICAL_TRIALS trial_result · 2021-01-20Clinical Trial Update: Role of Alprazolam in the Management of Acute Coronary Syndrome [Phase 1, Phase 2]
Phase 1/2 clinical trial exploring alprazolam for acute coronary syndrome management; status is unknown based on available data.
-
CLINICAL_TRIALS trial_result · 2021-01-11Clinical Trial Update: Effect of Methotrexate Carried by a Lipid Nanoemulsion on Left Ventricular Remodeling After STEMI [Phase 2, Phase 3]
Phase 2/3 trial evaluating methotrexate delivered via lipid nanoemulsion for effects on left ventricular remodeling after anterior wall myoc…
-
CLINICAL_TRIALS trial_result · 2021-01-06Clinical Trial Update: Study on the Clinical and Mechanism of Wenyang Huoxue Decoction in Treating Heart Failure After Myocardial Infarction [Phase 2]
Phase 2 trial update exploring Wenyang Huoxue Decoction for heart failure following myocardial infarction.
-
FDA approval · 2020-12-29FDA Approved: HEPARIN SODIUM — Original Application (BE Pharmaceuticals Inc.)
FDA approved the original ANDA for Heparin Sodium from BE Pharmaceuticals Inc., providing a generic version of heparin for anticoagulation.
-
FDA approval · 2020-12-29FDA Approved: HEPARIN SODIUM — Original Application (BE Pharmaceuticals Inc.)
The FDA approved BE Pharmaceuticals Inc.'s original application for Heparin Sodium (a generic anticoagulant). It is used to prevent and trea…
-
CLINICAL_TRIALS trial_result · 2020-12-23Clinical Trial Update: Antiplatelet Therapy Effect on Extracellular Vesicles in Acute Myocardial Infarction [Phase 4]
Phase 4 trial updating on antiplatelet therapy effects on extracellular vesicles in acute myocardial infarction; results posted.
-
CLINICAL_TRIALS trial_result · 2020-12-14Clinical Trial Update: Clinical and Metabonomics Study on the Treatment of Heart Failure After Myocardial Infarction With Modified Wenxin Decoction [Phase 2]
Phase 2 clinical trial update evaluating the effects of Modified Wenxin Decoction on heart failure post-myocardial infarction.
-
CLINICAL_TRIALS research · 2020-11-10Clinical Trial Update: Diagnostic Accuracy of Electrocardiogram for Acute Coronary Occlusion Resulting in Myocardial Infarction
A completed clinical trial assessing the diagnostic accuracy of electrocardiography for detecting acute coronary occlusion causing myocardia…
-
CLINICAL_TRIALS trial_result · 2020-10-29Clinical Trial Update: The Effects of the Dietary Supplement CardioFlex Q10 on Reducing Cardiovascular Disease Risk Factors in Adults [NA]
A completed clinical trial studying the effects of the dietary supplement CardioFlex Q10 on cardiovascular disease risk factors in adults.
-
CLINICAL_TRIALS trial_result · 2020-10-26Clinical Trial Update: Functional Assessment of the Infart-related Artery With Bioactive and Polymer-free Coronary Stents (The FUNCOMBO Trial) [Phase 4]
Phase 4 trial update evaluating a bioactive, polymer-free stent for endothelial dysfunction and coronary microvascular disease, completed.
-
CLINICAL_TRIALS trial_result · 2020-10-22Clinical Trial Update: Microcirculation In Acute Coronary Syndromes [Phase 4]
Phase 4 trial update on microcirculation in acute coronary syndromes completed.
-
CLINICAL_TRIALS trial_result · 2020-10-19Clinical Trial Update: Colchicine Cardiovascular Outcomes Trial (COLCOT) [Phase 3]
Phase 3 clinical trial update for the Colchicine Cardiovascular Outcomes Trial (COLCOT) completed with results posted in 2020.
-
CLINICAL_TRIALS trial_result · 2020-10-14Clinical Trial Update: A Polypill for Secondary Prevention of Ischemic Heart Disease [Phase 3]
Phase 3 trial update for a polypill intended for secondary prevention after ischemic heart disease.
-
FDA approval · 2020-09-17FDA Approved: LISINOPRIL — Supplemental Application (Exelan Pharmaceuticals Inc.)
The FDA approved a supplemental application for lisinopril by Exelan Pharmaceuticals Inc., related to a generic lisinopril product. This ref…
-
CLINICAL_TRIALS trial_result · 2020-09-16Clinical Trial Update: WJMSCs Anti-inflammatory Therapy in Acute Myocardial Infarction [Phase 2]
Phase 2 clinical trial update on WJMSCs anti-inflammatory therapy for acute myocardial infarction.
-
FDA approval · 2020-09-15FDA Approved: LISINOPRIL — Original Application (Chartwell RX, LLC)
FDA approves Chartwell RX, LLC's generic lisinopril (LISINOPRIL) under an original ANDA for the same indications as the brand. Indications i…
-
CLINICAL_TRIALS trial_result · 2020-08-28Clinical Trial Update: DPP-4 Inhibitors and Acute Myocardial Infarction:Effects on Platelet Function [Phase 3]
Phase 3 trial update examining how DPP-4 inhibitors affect platelet function during acute myocardial infarction.
-
CLINICAL_TRIALS trial_result · 2020-08-25Clinical Trial Update: Vorapaxar in Patients With Prior Myocardial Infarction Treated With Prasugrel and Ticagrelor [Phase 4]
Phase 4 trial assessing vorapaxar in patients with prior myocardial infarction treated with prasugrel and ticagrelor has completed with resu…